TTCI Delegation Strengthens International Collaboration and Celebrates Research Excellence at JACI 2026 in Japan
October 16, 2026
The 30th Annual Meeting of the Japanese Association of Cancer Immunology (JACI 2026)
● Date: July 22–24, 2026
● Location: Takamatsu, Japan
● TTCI Representatives: Prof. Nattiya Hirankarn (TTCI Director) and Dr. Wannakorn Khopanlert (Faculty of Medicine, Prince of Songkla University)
Highlights:
● Global Academic Engagement: Prof. Nattiya Hirankarn had the honor of meeting with Prof. Shimon Sakaguchi, a pioneer in the discovery and study of regulatory T cells (Tregs), supported and facilitated by JACI President Prof. Ikeda.
● Award-Winning Presentation: Representing TTCI and the Prince of Songkla University research team, Dr. Wannakorn Khopanlert delivered an oral presentation entitled "Academic PSU CAR-T: Favorable Safety, Long-Term Persistence and Durable Remissions in Heavily Pretreated Patients with Relapsed/Refractory B-Cell Malignancies" and was honored with the Excellent Presentation Award for General Topics.
Official Event Website: The 30th Annual Meeting of the Japanese Association of Cancer Immunology (JACI 2026)
● Date: July 22–24, 2026
● Location: Takamatsu, Japan
● TTCI Representatives: Prof. Nattiya Hirankarn (TTCI Director) and Dr. Wannakorn Khopanlert (Faculty of Medicine, Prince of Songkla University)
Highlights:
● Global Academic Engagement: Prof. Nattiya Hirankarn had the honor of meeting with Prof. Shimon Sakaguchi, a pioneer in the discovery and study of regulatory T cells (Tregs), supported and facilitated by JACI President Prof. Ikeda.
● Award-Winning Presentation: Representing TTCI and the Prince of Songkla University research team, Dr. Wannakorn Khopanlert delivered an oral presentation entitled "Academic PSU CAR-T: Favorable Safety, Long-Term Persistence and Durable Remissions in Heavily Pretreated Patients with Relapsed/Refractory B-Cell Malignancies" and was honored with the Excellent Presentation Award for General Topics.
Official Event Website: The 30th Annual Meeting of the Japanese Association of Cancer Immunology (JACI 2026)
